MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/hc9.0000000000000354

Медицинская библиотека · Hepatology communications · 2024

The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution.

Yu Xia, Liu Xinxin, Tan Wenting, Wang Xiaobo, Zheng Xin, Huang Yan, Chen Jinjun, Li Beiling, Meng Zhongji, Gao Yanhang, Qian Zhiping, Liu Feng, Lu Xiaobo, Shang Jia, Yan Huadong, Zheng Yubao, Zhang Weituo, Yin Shan, Gu Wenyi, Deng Guohong, Xiang Xiaomei, Zhou Yi, Hou Yixin, Zhang Qun, Xiong Shue, Liu Jing, Chen Ruochan, Long Liyuan, Jiang Xiuhua, Luo Sen, Chen Yuanyuan, Jiang Chang, Zhao Jinming, Ji Liujuan, Mei Xue, Li Jing, Li Tao, Zheng Rongjiong, Zhou Xinyi, Ren Haotang, Sheng Jifang, Li Hai, Shi Yu

Многоцентровое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Acute-on-chronic liver failure (ACLF) is a highly dynamic syndrome. The objective of this study was to delineate the clinical course of patients with HBV-ACLF and to develop a model to estimate the temporal evolution of disease severity.

METHODS

We enrolled eligible patients from 2 large, multicenter prospective cohorts. The ACLF grade, organ failures, and outcomes were assessed at multiple time points (days 1/4/7/14/21/28). Probabilities for ACLF transitions between these disease states and to death within 28 days were calculated using a multi-state model that used baseline information and updated ACLF status. The model was validated in independent patients.

RESULTS

Among all the 445 patients with HBV-ACLF, 76 represented disease progression, 195 had a stable or fluctuating course, 8 with improvement, and the remaining 166 with resolution within 28-day follow-up. New coagulation (63.64%) or renal failure (45.45%) was frequently observed during early progression. Patients with disease progression had a higher incidence of new episodes of ascites [10 (13.16%) vs. 22 (5.96%), p = 0.027] and HE [13(17.11%) vs. 21 (5.69%), p = 0.001], and a significant increase in white blood cell count. The multi-state model represented dynamic areas under the receiver operating characteristic curves ranging from 0.71 to 0.84 for predicting all ACLF states and death at 4, 7, 14, 21, and 28 days post-enrollment and from 0.73 to 0.94 for predicting death alone, performing better than traditional prognostic scores.

CONCLUSIONS

HBV-ACLF is a highly dynamic syndrome with reversibility. The multi-state model is a tool to estimate the temporal evolution of disease severity, which may inform clinical decisions on treatment.

Для цитирования: Yu Xia, Liu Xinxin, Tan Wenting, Wang Xiaobo, Zheng Xin, Huang Yan, Chen Jinjun, Li Beiling, Meng Zhongji, Gao Yanhang, Qian Zhiping, Liu Feng, Lu Xiaobo, Shang Jia, Yan Huadong, Zheng Yubao, Zhang Weituo, Yin Shan, Gu Wenyi, Deng Guohong, Xiang Xiaomei, Zhou Yi, Hou Yixin, Zhang Qun, Xiong Shue, Liu Jing, Chen Ruochan, Long Liyuan, Jiang Xiuhua, Luo Sen, Chen Yuanyuan, Jiang Chang, Zhao Jinming, Ji Liujuan, Mei Xue, Li Jing, Li Tao, Zheng Rongjiong, Zhou Xinyi, Ren Haotang, Sheng Jifang, Li Hai, Shi Yu. The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution.. Hepatology communications. 2024. DOI: 10.1097/hc9.0000000000000354.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.